We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Breast CT Imaging System Easier on Women

By HospiMedica International staff writers
Posted on 29 Dec 2010
While not a frontline screening tool, cone beam computed tomography (CBCT) might help diagnose difficult breast cancer cases.

Radiologist Avice O'Connell, MD, from the University of Rochester Medical Center (URMC; Rochester, NY, USA), summarized the studies conducted thus far on the cone beam computed tomography (CBCT) scanner, at the Radiological Society of North America annual scientific assembly in Chicago, IL, USA November 28 to December 3, 2010. More...
Dr. O'Connell is optimistic about the progress: The CBCT provides high-quality images, and significantly, is easier on women because it allows accurate breast scans without having to pull, flatten, and compress the tissue.

Moreover, early research showed that breast coverage and radiation dose is comparable to mammography. However, at this time researchers do not believe the CBCT is likely to replace mammography as a frontline screening tool. More studies are needed to verify its best usage in the clinic. "The CBCT imaging system has some significant advantages over current imaging modalities however its greatest potential may be as an additional tool for diagnosing difficult cases. It could be extremely useful in locating tumors that are obscured by dense breast tissue, or distinguishing between benign and malignant lesions,” said Dr. O'Connell, associate professor in imaging sciences and director of women's imaging for the Comprehensive Breast Care Center at the James P. Wilmot Cancer at URMC.

A team of URMC researchers introduced the CBCT system at the 2006 RSNA meeting. The CBCT scanner produces three-dimensional images while the breasts are in a more natural state. (Tomosynthesis is another new technology being developed for breast screening. It constructs a 3D image of the breast using multiple X-rays, whereas the CBCT is an actual 3D image, according to Dr. O'Connell) The patient undergoing a CBCT scan lies on her stomach on a cushioned exam table--the design of which is still being improved--as one breast at a time is suspended through an opening in the table. The radiation source is positioned so that exposure to the chest or other areas of the torso can be avoided.

The scanner takes 300 high-resolution images while circling the breasts for approximately 10 seconds, emitting a radiation dose that is similar to a diagnostic mammogram and within the limits set by the US Food and Drug Administration. Radiologists will also be able to use the CBCT images and related software to perform biopsies directly on the table, according to Dr. O'Connell.

Dr. O'Connell presented her findings at RSNA, which included an initial trial of 23 women who were known to be cancer-free and to have had routine, normal, screening mammograms, also volunteered to undergo scans on the CBCT system. The study's only objectives were to evaluate image quality, coverage, and radiation dose. Some of the volunteers had dense breasts, which are more difficult to screen and often require a higher dose of radiation to obtain additional views if a problem is suspected. Dense breast tissue is rather common: at least 25% of all women undergoing screening mammography, and particularly younger women and those who take hormone therapy, have dense tissue, which can greatly reduce the sensitivity of mammography.

Researchers discovered that the CBCT provided quality images of the entire breast, from the chest wall to the nipple, with a contrast resolution that was adequate to detect masses and calcifications 1 mm or larger. The study was published in August 2010 in the American Journal of Radiology.

A follow-up study of 42 women included volunteers who were known to have abnormal mammograms and in need of a biopsy. Researchers compared the mammography images to those from the CBCT scanner. The CBCT detected all abnormalities and cancerous lesions, O'Connell said. Data from this study is being presented for the first time at RSNA 2010, and has not yet been published in a peer-reviewed journal.

Dr. O'Connell has begun a new clinical trial in collaboration with the University of Massachusetts (Worchester, USA). The objective is to compare CBCT and mammography images of 75 lesions and 75 calcifications to the pathology reports from the biopsies. This will allow researchers to evaluate the accuracy of the scans further.

Additional studies are planned to investigate the use of CBCT for those who cannot receive an magnetic resonance imaging (MRI), for women with silicone breast implant ruptures, and to assess the response to breast cancer treatment in cases where the disease is more advanced at diagnosis. "As our studies continue, we are very excited about the potential of this technology and look forward to exploring many uses for the CBCT scanner in the clinic,” Dr. O'Connell added.

Related Links:
University of Rochester Medical Center


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Rapid Sepsis Test
SeptiCyte RAPID
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.